Strategy
MSTR
MARA Holdings
MARA
NVIDIA
NVDA
Tesla
TSLA
Coinbase
COIN
US Stock MarketDetailed Quotes
ALXO ALX Oncology
- 1.100
- +0.030+2.80%
Close Feb 28 16:00 ET
- 1.120
- +0.020+1.82%
Post 19:39 ET
58.02MMarket Cap-0.37P/E (TTM)
1.120High1.050Low334.01KVolume1.060Open1.070Pre Close365.88KTurnover1.05%Turnover RatioLossP/E (Static)52.74MShares17.82552wk High0.42P/B34.87MFloat Cap0.96352wk Low--Dividend TTM31.70MShs Float117.450Historical High--Div YieldTTM6.54%Amplitude0.963Historical Low1.095Avg Price1Lot Size
About ALX Oncology Company
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Company Profile
SymbolALXO
Company NameALX Oncology
Listing DateJul 17, 2020
Issue Price19.00
Founded2015
CEOMr. Jason Lettmann
MarketNASDAQ
Employees72
Fiscal Year Ends12-31
Address323 Allerton Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-466-7125
Websitehttp://www.alxoncology.com
Company Executives
- Name
- Position
- Salary
- Jason Lettmann
- Chief Executive Officer and Director
- 4.86M
- Shelly Pinto
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Dr. Alan B. Sandler, M.D.
- Chief Medical Officer
- --
- Dr. Jaume Pons, PhD
- President and Chief Scientific Officer
- 2.75M
- Harish Shantharam
- Chief Financial Officer
- --
- Dr. Corey S. Goodman,PhD
- Executive Chairman of the Board
- 206.61K
- Dr. Barbara Klencke, M.D.
- Independent Director
- --
- Rekha Hemrajani, M.B.A.
- Independent Director
- 181.02K
- Scott Garland
- Independent Director
- 105.66K
- Chris H. Takimoto, F.A.C.P.,M.D.,PhD
- Independent Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.